Cargando…
Evaluation of microvasculopathy using dual-energy computed tomography in patients with chronic thromboembolic pulmonary hypertension
The existence of microvasculopathy in patients with chronic thromboembolic pulmonary hypertension has been suggested. Recently, dual-energy computed tomography has been used to produce a sensitive iodine distribution map in lung fields to indicate microvasculopathy according to poor subpleural perfu...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829531/ https://www.ncbi.nlm.nih.gov/pubmed/33532057 http://dx.doi.org/10.1177/2045894020983162 |
_version_ | 1783641189093736448 |
---|---|
author | Onishi, Hiroyuki Taniguchi, Yu Matsuoka, Yoichiro Yanaka, Kenichi Izawa, Yu Tsuboi, Yasunori Mori, Shumpei Kono, Atsushi Nakayama, Kazuhiko Emoto, Noriaki Hirata, Ken-ichi |
author_facet | Onishi, Hiroyuki Taniguchi, Yu Matsuoka, Yoichiro Yanaka, Kenichi Izawa, Yu Tsuboi, Yasunori Mori, Shumpei Kono, Atsushi Nakayama, Kazuhiko Emoto, Noriaki Hirata, Ken-ichi |
author_sort | Onishi, Hiroyuki |
collection | PubMed |
description | The existence of microvasculopathy in patients with chronic thromboembolic pulmonary hypertension has been suggested. Recently, dual-energy computed tomography has been used to produce a sensitive iodine distribution map in lung fields to indicate microvasculopathy according to poor subpleural perfusion. Our aim was to evaluate the impact of microvasculopathy on pathophysiology in chronic thromboembolic pulmonary hypertension. According to the extent of poor subpleural perfusion, ninety-three interventional treatment-naïve patients were divided into poorly perfused (n = 49) or normally perfused group (n = 44). We assessed cardiopulmonary exercise test, right heart catheterization, and dual-energy computed tomography parameters for quantitative evaluation of lung perfusion of blood volume score. Lung perfusion of blood volume score in normally perfused group was significantly inversely correlated with pulmonary vascular resistance (pulmonary vascular resistance = 6816.1 × lung perfusion of blood volume score(−0.793), R(2) = 0.225, p < 0.01), but lung perfusion of blood volume score in poorly perfused group was not. Poorly perfused group had higher pulmonary vascular resistance (879 ± 409 dynes-s/cm(5) vs. 574 ± 279 dynes-s/cm(5), p < 0.01) and lower lung perfusion of blood volume score (22.1 ± 5.4 vs. 26.4 ± 6.6, p < 0.01) and % diffusing capacity for carbon monoxide divided by the alveolar volume (59.9 ± 15.4% vs. 78.8 ± 14.2%, p < 0.01). Perfusion of blood volume score in the normally perfused group showed an inverse correlation with pulmonary vascular resistance; however, that in poorly perfused group did not. Microvasculopathy might contribute to severe hemodynamics, apart from pulmonary vascular obstruction. In our experience, more than half of treatment-naïve chronic thromboembolic pulmonary hypertension patients have microvasculopathy. |
format | Online Article Text |
id | pubmed-7829531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-78295312021-02-01 Evaluation of microvasculopathy using dual-energy computed tomography in patients with chronic thromboembolic pulmonary hypertension Onishi, Hiroyuki Taniguchi, Yu Matsuoka, Yoichiro Yanaka, Kenichi Izawa, Yu Tsuboi, Yasunori Mori, Shumpei Kono, Atsushi Nakayama, Kazuhiko Emoto, Noriaki Hirata, Ken-ichi Pulm Circ Original Research Article The existence of microvasculopathy in patients with chronic thromboembolic pulmonary hypertension has been suggested. Recently, dual-energy computed tomography has been used to produce a sensitive iodine distribution map in lung fields to indicate microvasculopathy according to poor subpleural perfusion. Our aim was to evaluate the impact of microvasculopathy on pathophysiology in chronic thromboembolic pulmonary hypertension. According to the extent of poor subpleural perfusion, ninety-three interventional treatment-naïve patients were divided into poorly perfused (n = 49) or normally perfused group (n = 44). We assessed cardiopulmonary exercise test, right heart catheterization, and dual-energy computed tomography parameters for quantitative evaluation of lung perfusion of blood volume score. Lung perfusion of blood volume score in normally perfused group was significantly inversely correlated with pulmonary vascular resistance (pulmonary vascular resistance = 6816.1 × lung perfusion of blood volume score(−0.793), R(2) = 0.225, p < 0.01), but lung perfusion of blood volume score in poorly perfused group was not. Poorly perfused group had higher pulmonary vascular resistance (879 ± 409 dynes-s/cm(5) vs. 574 ± 279 dynes-s/cm(5), p < 0.01) and lower lung perfusion of blood volume score (22.1 ± 5.4 vs. 26.4 ± 6.6, p < 0.01) and % diffusing capacity for carbon monoxide divided by the alveolar volume (59.9 ± 15.4% vs. 78.8 ± 14.2%, p < 0.01). Perfusion of blood volume score in the normally perfused group showed an inverse correlation with pulmonary vascular resistance; however, that in poorly perfused group did not. Microvasculopathy might contribute to severe hemodynamics, apart from pulmonary vascular obstruction. In our experience, more than half of treatment-naïve chronic thromboembolic pulmonary hypertension patients have microvasculopathy. SAGE Publications 2021-01-20 /pmc/articles/PMC7829531/ /pubmed/33532057 http://dx.doi.org/10.1177/2045894020983162 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Article Onishi, Hiroyuki Taniguchi, Yu Matsuoka, Yoichiro Yanaka, Kenichi Izawa, Yu Tsuboi, Yasunori Mori, Shumpei Kono, Atsushi Nakayama, Kazuhiko Emoto, Noriaki Hirata, Ken-ichi Evaluation of microvasculopathy using dual-energy computed tomography in patients with chronic thromboembolic pulmonary hypertension |
title | Evaluation of microvasculopathy using dual-energy computed tomography
in patients with chronic thromboembolic pulmonary hypertension |
title_full | Evaluation of microvasculopathy using dual-energy computed tomography
in patients with chronic thromboembolic pulmonary hypertension |
title_fullStr | Evaluation of microvasculopathy using dual-energy computed tomography
in patients with chronic thromboembolic pulmonary hypertension |
title_full_unstemmed | Evaluation of microvasculopathy using dual-energy computed tomography
in patients with chronic thromboembolic pulmonary hypertension |
title_short | Evaluation of microvasculopathy using dual-energy computed tomography
in patients with chronic thromboembolic pulmonary hypertension |
title_sort | evaluation of microvasculopathy using dual-energy computed tomography
in patients with chronic thromboembolic pulmonary hypertension |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829531/ https://www.ncbi.nlm.nih.gov/pubmed/33532057 http://dx.doi.org/10.1177/2045894020983162 |
work_keys_str_mv | AT onishihiroyuki evaluationofmicrovasculopathyusingdualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertension AT taniguchiyu evaluationofmicrovasculopathyusingdualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertension AT matsuokayoichiro evaluationofmicrovasculopathyusingdualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertension AT yanakakenichi evaluationofmicrovasculopathyusingdualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertension AT izawayu evaluationofmicrovasculopathyusingdualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertension AT tsuboiyasunori evaluationofmicrovasculopathyusingdualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertension AT morishumpei evaluationofmicrovasculopathyusingdualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertension AT konoatsushi evaluationofmicrovasculopathyusingdualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertension AT nakayamakazuhiko evaluationofmicrovasculopathyusingdualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertension AT emotonoriaki evaluationofmicrovasculopathyusingdualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertension AT hiratakenichi evaluationofmicrovasculopathyusingdualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertension |